WorldPharmaNews
  • Home
  • Business
  • Research
  • Jobs
  • Events
  • Regulatory

At ASCO 2017 clinicians present new evidence about Watson cognitive technology and cancer care

Details
Business
01 June 2017
IBMIBM Watson Health (NYSE: IBM) and its collaborators today unveiled data that will be presented at ASCO 2017, demonstrating the clinical utility of Watson for Oncology trained by Memorial Sloan Kettering as well as Watson for Clinical Trial Matching (CTM). IBM also announced the latest updates on adoption of Watson oncology offerings,
Read more ...

SERMO unveils first global physician-to-physician drug ratings tool

Details
Business
11 May 2017
SERMOSERMO, the largest global social network for physicians with 650,000 members worldwide, has announced the groundbreaking new "Drug Ratings" tool. Drug Ratings is the first and only global peer-to-peer prescription drug review system sourced exclusively from verified licensed physicians. With more than a quarter million ratings and 20,000 comments from doctors worldwide to date in the beta release, the Ratings platform is quickly becoming the largest global database of physician feedback on drugs.
Read more ...

Grants4Apps Accelerator and new Dealmaker now open for submissions

Details
Business
03 May 2017
Grants4Apps Accelerator and new Dealmaker now open for submissions
The Grants4Apps Accelerator Berlin is back and this time with an additional track for the mature startups out there: The Dealmaker. Up to five startups will be selected for the 100-day Accelerator program in Berlin. The new Dealmaker is all about quality facetime between you and Grants4Apps experts for one full day.
Read more ...

LEO Innovation Lab CEO wins eyeforpharma Customer Innovator Award

Details
Business
14 March 2017
LEO Innovation LabLEO Innovation Lab is proud to announce that our CEO Kristian Hart-Hansen has won the eyeforpharma Customer Innovator Award. Kristian has spearheaded the growth of the LEO Innovation Lab since it's conception in 2015 with just six team members, to a thriving incubator of over 80 people and 15 projects today. The lab was established by LEO Pharma as an independent initiative to focus on using digital innovation to help individuals manage chronic skin conditions.
Read more ...

Mindprint implements market-leading automation solution for Ockham Oncology

Details
Business
12 June 2014
Mindprint Inc. and Ockham Development, Inc. have implemented an innovative automation software system to help the global CRO manage trials efficiently to ensure a more focused approach to its core oncology mission.
Read more ...

Astellas and Ambrx initiate collaboration for discovery and development of antibody drug conjugates for oncology

Details
Business
07 April 2013
AstellasAstellas Pharma Inc. (Tokyo: 4503, "Astellas") entered into a collaboration with Ambrx Inc. ("Ambrx") for the discovery and development of novel antibody drug conjugates ("ADCs"). ADCs allow for the targeted delivery of drugs to the target tissue. Ambrx creates optimized ADCs using its site-specific conjugation technology along with proprietary linkers and payloads.
Read more ...

Luqa Pharmaceuticals and Stratpharma enter into an exclusive agreement

Details
Business
08 August 2012
Luqa Pharmaceuticals announced today that it has entered into an exclusive agreement with Stratpharma AG of Switzerland to promote, sell, and distribute Strataderm®, in the People's Republic of China.
Read more ...

More Pharma News ...

  1. Sanofi and Astellas to dissolve sanofi-aventis Yamanouchi Pharmaceutical Inc.
  2. Forest Laboratories Completes Acquisition of Clinical Data, Inc.
  3. Forest Laboratories, Inc. Finalizes Previously Disclosed Settlement of U.S. Government Investigations
  4. Covex S.A. creates 2000 jobs with the onset of a new agroindustrial project in Latin America
  5. Luitpold Pharmaceuticals, Inc. Acquires PharmaForce, Inc.
  6. Onyx Pharmaceuticals to Acquire Proteolix, Inc.
  7. Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Next Generation Anti-Infective
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
  • End
admet_300x250

Business & Industry

  • FDA grants Breakthrough Therapy Designation for Roche's Hemlibra in haemophilia A without inhibitors
  • Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials
  • Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford
  • Bristol-Myers Squibb announces worldwide collaboration with Janssen to develop and commercialize next-generation cardiovascular therapy
  • GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

Research & Development

  • Personalized tumor vaccine shows promise in pilot trial
  • New class of drugs could help tackle treatment-resistant cancers
  • New immunotherapy for lung cancer shows promise of success
  • Human drug trials are compromised by poor reporting of animal research
  • 'Coffee filter' helps make new cancer drug Z-endoxifen 1,000 times cheaper
  • Researchers propose key elements of antimicrobial stewardship for hospitals worldwide
  • When drugs are wrong, skipped or make you sick: The cost of non-optimized medications

Conferences & Events

  • SMi presents the 2nd annual conference on Pharmaceutical Microbiology West Coast
  • Introducing SMi's 6th annual conference on Pharmaceutical Freeze Drying Technology this June 2018
  • Adaptive Designs in Clinical Trials Conference 2018
  • Drug Safety 2018
  • Controlled Release Delivery Conference 2018
  • Superbugs & Superdrugs Conference 2018
  • Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference 2018

Regulatory Affairs

  • FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
  • FDA approves new treatment for certain digestive tract cancers
  • FDA approves first treatment for breast cancer with a certain inherited genetic mutation
  • FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response
  • FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
  • FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care
  • FDA launches public education campaign to encourage adult smokers trying to quit cigarettes
  1. You are here:  
  2. Home
  3. Business

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Submit Your News!

Latest WORLD PHARMA JOBS

  • Senior Clinical Data Manager
  • Director Technology Strategy and Innovation

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2006 - 2017. All Rights Reserved. Our top projects: World Pharma News | WORLD PHARMA JOBS | PharmaNews.eu | eHealthNews.eu | (HEALTH IT) SPACE